The goal of personalized medicine has ushered in the transition from empirical medicine to molecular medicine. Thus during research, biobanks are key infrastructures for biomedical R&D because at one time or another, these biospecimens have been stored in a biobank. Well-annotated biospecimens and their associated clinical data accelerate translational and clinical research discoveries. However, high-throughput molecular sequencing and increased biosample variety have introduced significant informatics challenges for biobanking infrastructures. Meanwhile, the lack of high-quality biospecimens both stalls projects and limits research advances.
Cambridge Healthtech Institute’s Ninth International Leaders in Biobanking Congress addresses biospecimen science, management, and applications, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research, leading to the goal of personalized medicine.
The meeting will cover a range of topics and case studies utilizing biospecimen science and biobanking management.
Those encouraged to submit a title and summary of their experiences for consideration of presentation include:
- Molecular researchers utilizing biospecimens for their research
- Biobankers providing biospecimens, developing biopreservation technologies standards and protocols and managing resources while navigating regulatory compliance
- Clinical trial professionals collecting, analyzing and utilizing data
To submit a proposal for consideration, please click here.
Deadline for priority consideration is March 17, 2017.
All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biomedical companies, regulators and those from academic research centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497
Email: mabrown@healthtech.com
For sponsorship and exhibit sales information, please contact:
Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email: cbenton@healthtech.com